Global Engineering Services Industry Market Research Report Now Available from IBISWorld


Los Angeles, CA (PRWEB) April 22, 2012

The global market for engineering services consists of the work performed by consultant engineering firms along with the in-house services undertaken by construction contractors, manufacturers, government agencies and utility owners. According to IBISWorld industry analyst Anthony Kelly, the industry’s performance is principally driven by the trends into construction, manufacturing and mining developments (particularly in the large industrial economies) and increasingly from work in the fields of technological development and the sustainable environment. Over the past decade the industry has expanded its operations by broadening across a wider range of multidisciplinary services, by the trend towards globalization and through the outsourcing of services by public authorities and major corporations.

The Global Engineering Services industry is one of the largest professional service industries, generating revenue of about $ 530 billion in 2012 (up 3.0% on the previous year), and employing 2.9 million people. Industry value added currently totals $ 318 billion, or 0.6% of the world’s GDP, two-thirds of which represents payments to employees and the balance the industry’s operating profit. The industry’s performance deteriorated during the late 2000s with the onset of recession in several of the largest developed economies and the subsequent decline in construction and industrial production. Despite the current improvement, industry revenue is estimated to average subdued growth by 0.5% per annum over the five years through 2012.

?International trade represents a significant share of industry activity (10.6% of revenue in 2012) and is mainly confined to relatively few large-scale consulting engineering firms that are capable of operating outside national boundaries,? said Kelly. A feature of the industry that has accompanied globalization has been the amalgamation of the larger players to achieve scale economies, broaden the market and strengthen the human and financial resources (consistent with the trend evident in other knowledge-based industries such as accounting, law, advertising and architecture).

The Global Engineering Services industry has a low concentration of ownership, with the four largest companies accounting for about 6.0% of annual industry revenue. The largest players in the global market for engineering services include URS Corporation, SNC-Lavalin Group, Bechtel Group, Jacobs Engineering Group, Fluor Corporation, AECOM Technology Corporation, CH2M HILL Companies, WS Atkins plc, and Altran Technologies. Despite this low concentration, there has been a trend over the past decade for the consolidation of the operations of many of the world’s leading consulting engineering firms, through mergers or strategic alliances. These large-scale, multidisciplined, multinational companies are well placed to win contracts in most markets. For more information, visit IBISWorld?s Global Engineering Services in the US industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld

Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld industry Report Key Topics

The industry comprises establishments engaged in applying physical laws and principles of engineering in the design, development and use of machines, materials, instruments, structures, processes and systems. The assignments may involve the provision of advice, preparation of feasibility studies, preparation of preliminary and final plans and designs, the provision of technical services on construction and project evaluation.

Industry Performance

Executive Summary

Key External Drivers

Current Performance

Industry Outlook

Industry Life Cycle

Products & Markets

Supply Chain

Products & Services

Major Markets

Globalization & Trade

Business Locations

Competitive Landscape

Market Share Concentration

Key Success Factors

Cost Structure Benchmarks

Barriers to Entry

Major Companies

Operating Conditions

Capital Intensity

Key Statistics

Industry Data

Annual Change

Key Ratios

About IBISWorld Inc.

Recognized as the nation?s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.







Related Wellness Press Releases

Global Neurodegenerative Drugs Market to Exceed $43.4 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

San Jose, CA (PRWEB) April 12, 2010

Neurodegenerative diseases, caused due to neuron deficiency or dysfunction of the spinal cord or brain cells, are destructive in nature, as regeneration of affected cells is not possible and results in ultimate damage or death. Major neurodegenerative diseases with significant unmet medical needs include Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Huntington’s disease. There are only a few treatment available for some of these diseases, and several of these treatment options provide only symptomatic relief. For a few others such as the Huntington’s disease, there is still not a single therapy available that can treat the disease.

The United States dominates the world neurodegenerative drugs market as stated by the new market research report on Neurodegenerative Drugs market. The market exhibits huge potential considering the high rates of prevalence of Alzheimer’s and Parkinson’s disease. The market is largely untapped due to under-diagnosis owing to lack of proper diagnostics, and lack of therapies that can effectively and safely prevent or treat the diseases.

Multiple Sclerosis represents the largest segment of the neurodegenerative drugs market. The multiple sclerosis drugs market is all set for a major transformation with new drugs in pipeline awaiting approval in near future. Most pipeline drugs are showing promising results in terms of reducing disease progression and other end-points compared to existing drugs. The most promising multiple sclerosis candidates include oral therapies such as Sanofi-aventis’ Teriflunomide, Active Biotech’s Laquinimod, Merck’s Cladribine and Novartis’ FTY720.

Alzheimer’s is the fastest growing segment of the neurodegenerative drugs market. The currently available drugs for Alzheimer’s disease not only provide limited efficacy, but may also result in serious adverse effects. There are issues with acceptability and safety, and some patients may even fail to respond to treatment with available drugs. The outlook appears interesting considering that a few leading products are lined up for patent expiry, including Namenda and Exelon, while there are others in pipeline that promise to deliver on the failure of available therapies.

Key players profiled in the report include Amarin Corporation Plc; AstraZeneca Plc; Avanir Pharmaceuticals Inc.; Avigen Inc.; Bayer Schering Pharma AG; Boehringer Ingelheim GmbH; Biogen Idec Inc.; Bristol-Myers Squibb Co.; Biovail Corporation; Ceregene, Inc.; Eisai, Inc.; Elan Pharmaceuticals; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline plc; H. Lundbeck A/S; Merz Pharmaceuticals GmbH; Merck Serono; Mitsubishi Tanabe Pharma Corporation; Neurologix, Inc.; NeuroSearch A/S; Novartis AG; Pfizer Inc.; Sanofi-aventis S.A.; Shire Pharmaceuticals Group Plc; Teva Pharmaceutical Industries Limited; Valeant Pharmaceuticals International; and Wyeth Pharmaceuticals, Inc.

The report titled “Neurodegenerative Drugs: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, market drivers, market inhibitors, competitive scenario, clinical trials, product introductions/approvals, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including The United States, Europe and Rest of World. The study analyzes market data and analytics in terms of value sales for neurodegenerative drugs by disease type, including Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Other Diseases.

For more details about this comprehensive market research report, please visit -

http://www.strategyr.com/Neurodegenerative_Drugs_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Web Site http://www.StrategyR.com/

###





Find More Alzheimer Disease Press Releases

Discount Membership Card Company has Made a Major New Year’s Resolution on Global Expansion

Atlanta, GA (PRWEB) January 12, 2012

MyWorldPlus, sometimes referred to as MWP, is a network marketing program that was created by Ben Glinsky. The company mainly involves itself in the sales of discount membership cards. Today was the big announcement: CEO Ben Glinsky officially went global with MyWorldPlus, expanding the company in Argentina, Austria, Australia, Belgium, Brazil, Canada, Columbia, Costa Rica, Cyprus, Denmark, Ecuador, El Salvador, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Japan, Luxembourg, Latvia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Singapore, South Africa, Spain, Sweden, Slovenia, United Kingdom (includes England, Scotland and Ireland), the United States and Venezuela. Mr. Glinsky launched MyWorldPlus on March 15th, 2007 with its unique blend of money-saving coupons, cash back online shopping and gift cards; teamed together with a incredible powerline marketing system, this program will be hard to beat.

In addition, there are some new powerful developments in store for the MyWorldPlus team members/associates, with developments coming to market fund raising opportunities to charitable organizations and a solution for business owners to offer employee discount cards as well.

###



Victims of Sepsis Tell Their Harrowing Survival Stories as Feinstein Institute Prepares to Host Global Conference on Killer of 200K+ Americans Annually


Lake Success, NY (Vocus) September 29, 2010

For Jackie Wang, it was just a garden-variety infection that was slowing her down. But her doctor realized that the 29-year-old Manhasset, NY woman was sick enough to go to the emergency room. By the time she got to North Shore University Hospital in Manhasset, her body?s immune system had waged a full-scale attack on her lungs and threatened other organs ? and her life.

Ms. Wang is among the half-million Americans every year who develop sepsis or septic shock, a life-threatening immune response that claims more than 200,000 lives annually in the US. Jackie Wang is one of the lucky ones. She survived.

When she awoke from a 10-day induced coma that was necessary to save her life and was told that she had sepsis, the young woman looked puzzled: ?What?s sepsis?? she asked. She is not alone. More than 60 percent of adults do not know what sepsis is, according to a new survey sponsored by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. The survey of 1,000 adults throughout the United States found that:

Licensing Executives Society International Hosts Member Society Delegates from Six Continents at Upcoming LESI Global Technology Impact Forum


Alexandria, VA (PRWEB) December 21, 2011

The Licensing Executives Society International, Inc. (LESI; http://www.LESI.org) announced today that it will host delegates from six continents at the upcoming LESI Global Technology Impact Forum (GTIF), taking place on January 23-25, 2012 in Geneva, Switzerland.

The Licensing Executives Society represents more than 10,000 individual members in over 90 countries. Delegates attending GTIF represent the following LES Member Societies: Andean Community, Arab Countries, Australia & New Zealand, Benelux, Brazil, Britain & Ireland, Chile, China, Chinese Taipei, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Japan, Korea, Mexico, Philippines, Scandinavia, Singapore, South Africa, Spain & Portugal, Switzerland, Turkey, and USA/Canada.

These delegates will discuss topics related to the management of intellectual property (IP) and technology transfer to further economic growth, as well as next generation IP market development.

Visit YouTube to hear more from LESI members: http://www.youtube.com/user/GTIForum/videos

?GTIF has become a focal point of discussion for policy makers and professionals seeking to advance the business of intellectual property on a global scale,? explained LESI President James E. Malackowski.

At present, over 25 leading global organizations, including the World Intellectual Property Organization (WIPO), World Trade Organization (WTO) and the International Chamber of Commerce (ICC), representing three interest groups ? Intellectual Property Protection & Harmonization, Trade & Economic Development, and Technology Transfer & Standards ? will participate.

More than 100 business and legal executives are also expected. GTIF is open to the public with registration found at http://www.gtiforum.org/register.

About the LESI Global Technology Impact Forum (GTIF)

The LESI Global Technology Impact Forum (GTIF) is an annual event, hosted by the Licensing Executives Society International, Inc. (LESI), developed to coordinate and publicize the efforts of premier global non-profit and non-governmental organizations dedicated to the promotion of IP licensing and technology transfer for the betterment of mankind. Invited organizations are representative of three interest groups: IP Protection & Harmonization; Trade & Economic Development; and Technology Transfer & Standards.

Founded in 1972, the mission of the LESI is to function as a non-profit professional organization supporting LES member societies in: setting and maintaining global professional standards for licensing executives; facilitating professional networking between members of LES societies; providing quality educational content for member societies; and serving as liaison between leading global organizations and policy forums concerning the significance and importance of licensing and other transfer of technology and intellectual property rights.

###





Travelwire Global Inc. Offers Signature Deals, Event Packages and Custom Travel Planning

New York, NY (PRWEB) December 08, 2011

New global travel and tour provider, TravelwireGlobal.com, combines the convenience of booking travel online with a personal touch and the best prices for every aspect of a business trip or vacation getaway from flights, hotels and car rentals to cruises and custom tours.

TravelwireGlobal.com has also launched their Signature Deals feature offering value added rates at small and boutique hotels, exclusive villas and all-inclusive resorts. The inaugural Signature Deal is a four-night beach getaway at the Rondel Village on Jamaica?s stunning Seven Mile Beach for just $ 199.00 per person in a Superior Room for bookings now through December 28, 2011 and travel January 6 – 29, 2012, and $ 149.00 per person for stays May 7 – June 28, 2012 when booked by March 15, 2012.

The company offers 24-hour Signature Personal Service to assist travelers in planning all aspects of their trip. And, with recurring uncertainties that go hand-in-hand with travel today, the TravelwireGlobal.com team is on-call to handle re-bookings as necessary to make sure their clients reach their destinations and all expectations are met.

TravelwireGlobal.com brings its knowledge and expertise in North America and the Caribbean to its Signature Event Packages for some of the hottest tickets including the Jamaica Jazz & Blues Festival, Reggae Sumfest and the New Orleans Jazz and Heritage Festival. With teams on the ground, Travelwire Global ensures that its guests enjoy a seamless event destination experience with every aspect of their booking, so all the traveler has to worry about is what to wear.

?As a frequent business traveler I was always put off by the mechanical way in which travel arrangements were handled online. I wanted to know there was a person who cared about my travel plans,? says Oliver Huie who founded TravelwireGlobal.com on the premise that it be a company that offered service and support. ?The mission of our experienced staff is to bring the world to the finger tips of both the seasoned, frequent traveler as well as someone who saves all year to go on a vacation, and have both experience a personal touch when making their travel arrangements.?

Airline ticket bookings made online with TravelwireGlobal.com are confirmed within five hours and include a service fee starting at $ 20.00 per ticket for domestic flights. There is a $ 30.00 fee per booking for reservations made with Travelwire Global?s Signature Personal Service agents.

For more information or to make a reservation visit travelwireglobal.com, call toll-free 1-800-586-1522, or 1-718-766-9995.

###





More Wellness Press Releases

Global Genetic Testing Market to Reach US$1.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

San Jose, CA (Vocus/PRWEB) January 11, 2011

Genetic testing represents the most rapidly expanding segment of the molecular diagnostics market worldwide. Molecular diagnostics is the fastest growing segment in the In-Vitro Diagnostics (IVD) market. Key factors fostering growth in the molecular diagnostics market include increasing awareness about human genome, newer technologies and innovation for accurate detection and faster screening. With increasing number of aging population globally, countries across the world face the challenge of preventing age-related diseases, such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics, including genetic testing. Genetic testing, which of-late has been transforming itself from service-driven to product-driven market, is expected to provide an impetus to diagnostic companies for the expansion of their operations. Advancements in genetic testing field enable physicians to determine patients? health at different stages of the diagnostic treatment process.

Growing incidence of genetic diseases unravels new opportunities for genetic testing. The market is likely to expand for screening the newborns, diagnosing rare and fatal disorders, and predicting the probability of occurrence of diseases, such as Huntington. Genetic tests for newborn screening are expected to expand immensely over the coming years. In addition, with advances in genetic testing procedures, tests would be focused on early detection of Alzheimer disease, hemochromatosis, breast cancer, colorectal cancer, diabetes in young people, and rare forms of amyotrophic lateral sclerosis. Genetic testing identifies finest cancer treatment for specific patients. Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families.

The US represents the largest market for genetic testing worldwide, as stated by the new market research report on Genetic Testing. Genetic counseling services are on the rise, specifically in the US. Presently, there are around 2,780 certified genetic counselors operating in the United States. Direct-to-Consumer genetic testing is expected to open new avenues in the US, for companies looking for areas to further expand their range of screening tests. DTC genetic testing method involves marketing genetic tests directly to consumers without involvement of independent healthcare provider.

The US is witnessing dramatic changes in the DNA-based testing industry, with the advent of transformational technologies, which are extending the scope of complicated genomic and genetic testing into clinical and medical laboratories, which conduct tests on individual patients for identifying genes linked to certain medical disorders.

Major players profiled in the report include Abbott Laboratories, Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data Inc., Orchid Cellmark Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp., Roche Molecular Diagnostics Inc. among others.

The research report titled “Genetic Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the genetic testing market, current market trends, key growth drivers, new product innovations/launches, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the global genetic testing market for the years 2007 through 2015 for the regions, including US, Canada, Japan, Europe, and Rest of World. The report also analyzes the US market for genetic testing by application type – Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine. Also, a seven-year (2000-2006) historic analysis is provided for additional market perspective.

For more details about this comprehensive market research report, please visit ? http://www.strategyr.com/Genetic_Testing_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world?s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

# # #





Global Genetic Testing Market to Reach US$1.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

San Jose, CA (Vocus/PRWEB) January 11, 2011

Genetic testing represents the most rapidly expanding segment of the molecular diagnostics market worldwide. Molecular diagnostics is the fastest growing segment in the In-Vitro Diagnostics (IVD) market. Key factors fostering growth in the molecular diagnostics market include increasing awareness about human genome, newer technologies and innovation for accurate detection and faster screening. With increasing number of aging population globally, countries across the world face the challenge of preventing age-related diseases, such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics, including genetic testing. Genetic testing, which of-late has been transforming itself from service-driven to product-driven market, is expected to provide an impetus to diagnostic companies for the expansion of their operations. Advancements in genetic testing field enable physicians to determine patients? health at different stages of the diagnostic treatment process.

Growing incidence of genetic diseases unravels new opportunities for genetic testing. The market is likely to expand for screening the newborns, diagnosing rare and fatal disorders, and predicting the probability of occurrence of diseases, such as Huntington. Genetic tests for newborn screening are expected to expand immensely over the coming years. In addition, with advances in genetic testing procedures, tests would be focused on early detection of Alzheimer disease, hemochromatosis, breast cancer, colorectal cancer, diabetes in young people, and rare forms of amyotrophic lateral sclerosis. Genetic testing identifies finest cancer treatment for specific patients. Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families.

The US represents the largest market for genetic testing worldwide, as stated by the new market research report on Genetic Testing. Genetic counseling services are on the rise, specifically in the US. Presently, there are around 2,780 certified genetic counselors operating in the United States. Direct-to-Consumer genetic testing is expected to open new avenues in the US, for companies looking for areas to further expand their range of screening tests. DTC genetic testing method involves marketing genetic tests directly to consumers without involvement of independent healthcare provider.

The US is witnessing dramatic changes in the DNA-based testing industry, with the advent of transformational technologies, which are extending the scope of complicated genomic and genetic testing into clinical and medical laboratories, which conduct tests on individual patients for identifying genes linked to certain medical disorders.

Major players profiled in the report include Abbott Laboratories, Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data Inc., Orchid Cellmark Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp., Roche Molecular Diagnostics Inc. among others.

The research report titled “Genetic Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the genetic testing market, current market trends, key growth drivers, new product innovations/launches, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the global genetic testing market for the years 2007 through 2015 for the regions, including US, Canada, Japan, Europe, and Rest of World. The report also analyzes the US market for genetic testing by application type – Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine. Also, a seven-year (2000-2006) historic analysis is provided for additional market perspective.

For more details about this comprehensive market research report, please visit ? http://www.strategyr.com/Genetic_Testing_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world?s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

# # #





Related Alzheimer Disease Press Releases

Global Genetic Testing Market to Reach US$1.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

San Jose, CA (Vocus/PRWEB) January 11, 2011

Genetic testing represents the most rapidly expanding segment of the molecular diagnostics market worldwide. Molecular diagnostics is the fastest growing segment in the In-Vitro Diagnostics (IVD) market. Key factors fostering growth in the molecular diagnostics market include increasing awareness about human genome, newer technologies and innovation for accurate detection and faster screening. With increasing number of aging population globally, countries across the world face the challenge of preventing age-related diseases, such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics, including genetic testing. Genetic testing, which of-late has been transforming itself from service-driven to product-driven market, is expected to provide an impetus to diagnostic companies for the expansion of their operations. Advancements in genetic testing field enable physicians to determine patients? health at different stages of the diagnostic treatment process.

Growing incidence of genetic diseases unravels new opportunities for genetic testing. The market is likely to expand for screening the newborns, diagnosing rare and fatal disorders, and predicting the probability of occurrence of diseases, such as Huntington. Genetic tests for newborn screening are expected to expand immensely over the coming years. In addition, with advances in genetic testing procedures, tests would be focused on early detection of Alzheimer disease, hemochromatosis, breast cancer, colorectal cancer, diabetes in young people, and rare forms of amyotrophic lateral sclerosis. Genetic testing identifies finest cancer treatment for specific patients. Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families.

The US represents the largest market for genetic testing worldwide, as stated by the new market research report on Genetic Testing. Genetic counseling services are on the rise, specifically in the US. Presently, there are around 2,780 certified genetic counselors operating in the United States. Direct-to-Consumer genetic testing is expected to open new avenues in the US, for companies looking for areas to further expand their range of screening tests. DTC genetic testing method involves marketing genetic tests directly to consumers without involvement of independent healthcare provider.

The US is witnessing dramatic changes in the DNA-based testing industry, with the advent of transformational technologies, which are extending the scope of complicated genomic and genetic testing into clinical and medical laboratories, which conduct tests on individual patients for identifying genes linked to certain medical disorders.

Major players profiled in the report include Abbott Laboratories, Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data Inc., Orchid Cellmark Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics Corp., Roche Molecular Diagnostics Inc. among others.

The research report titled “Genetic Testing: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the genetic testing market, current market trends, key growth drivers, new product innovations/launches, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the global genetic testing market for the years 2007 through 2015 for the regions, including US, Canada, Japan, Europe, and Rest of World. The report also analyzes the US market for genetic testing by application type – Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine. Also, a seven-year (2000-2006) historic analysis is provided for additional market perspective.

For more details about this comprehensive market research report, please visit ? http://www.strategyr.com/Genetic_Testing_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world?s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

# # #





Global Wine Market to Reach 26.12 Billion Liters by 2015, According to a New Report by Global Industry Analysts, Inc.

San Jose, California (Vocus/PRWEB) February 11, 2011

Wine, the niche category in the alcoholic beverages market is headed towards a healthy future with a steady growth forecast over the review period. The underlying health benefits of wine would also enable the segment to encroach the markets of beer and spirit, the other two segments. Recent research findings confirm the fact that moderate consumption of wine prevents heart disease, cancer, Alzheimer?s disease as well as muscular degeneration. High publicity received by these findings is spurring consumption of wine at home and at horeca (hotels, restaurants and cafes) outlets, particularly in non-wine producing countries. Developing countries like Russia, China, Australia and India, to name a few, are expected to drive future growth in the market. Changing lifestyles in these countries, which mostly mimic Western lifestyles, is proving to be a major win for the growth in wine consumption. Previously, interest in wines was confined to middle-aged customers, today a growing base of younger consumers are exhibiting a marked preference for wine over other alcoholic beverages.

New players entering the market and greater focus and investments in advertising and marketing campaigns intensified competition in the market place. The market has witnessed an unprecedented increase in wine sales through the Internet over the past few years. Although conventional wine producing European countries such as France, Spain and Italy still dominate the global market, they are facing stiff competition from new world wine regions like China and Australia, to name a few, which are progressing at a rapid pace with large-scale production, clever marketing strategies and competitive pricing. Regions including the US, Australia, Chile, New Zealand, South Africa and Argentina increased their combined share in the world market from 23% in 2005 to 30% by the end of 2008. With the availability of improved, latest technical know-how and equipment the new world regions are able to consistently produce good quality wines. Presently, the market is reeling under intense price pressures, triggered by rising competition and global oversupply.

The global market for wine witnessed a slowdown in growth during the recessionary years 2008 and 2009. The economic crisis and the subsequent deceleration in consumption, which added to the already existing problem of over production, adversely affected the global wine industry. The sharp decline was primarily attributed to a drastic reduction in consumption in the European Union, the largest market for wines worldwide. Maximum declines were witnessed in Spain and France while outside Europe, it was the US that recorded the highest decline. Developed markets of the US and Europe were more affected than the emerging markets of Asia-Pacific, Latin America, Eastern Europe and Australasia. During 2009, global grape production also fell. Segment wise, Champagne recorded the highest decline in volume as well as value sales in 2009. Champagne exports declined by 45% in terms of value and 40% in terms of volume during 2009. While the world?s major wine consuming region, Europe takes a back seat with consumption in major countries, such as France, slowing down, Asia-Pacific, driven by China is poised to grab large chunk of Europe?s share in the foreseeable future. The economic downturn also led to the trend of consumers readily trading down to cheaper wine varieties, shunning the more exclusive, expensive wines.

The wine industry reverted back on the path of gradual recovery, beginning 2010, with improved revival trends reported by global suppliers. Despite poor harvests in some of the major supplying nations, the average per bottle price managed to show improvement. The year 2010 also witnessed improvements in the export and import scenario in line with the improving global economy.

Europe positions itself as the single largest consumer and producer of wines, amassing a lion?s share of the worldwide market, as stated by the new research report on Wine. European countries including France, Spain and Italy capture the majority share of wine production in the region. Next to Europe, the US and Asia-Pacific rank as the other most significant wine consumers and producers worldwide. Wine industry in Asia-Pacific remained buoyant even during the volatile economic recession, and is projected to register the overall fastest growth both in terms of volume and value terms through 2015. The rapidly emerging economy in the region, China, is slated to witness an unprecedented increase in wine consumption and is poised to become a major contender in the global wine industry in future. By product group, the Still Wine category completely dominates the wine market in terms of sheer size. However, with respect to growth pace, Fortified Wine segment is expected to lead the way for the assessment period 2007-2015.

Key participants profiled in the report include Bacardi Limited, Brown-Forman Corporation, Castel Group, Constellation Brands Inc., Robert Mondavi Winery, Constellation Wines Australia, E.&J. Gallo Winery, Kendall-Jackson Wine Estates Ltd, Lanson BCC, Maison Burtin, LVMH Mo